Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 5271203, 10 pages
https://doi.org/10.1155/2017/5271203
Research Article

Growth Differentiation Factor-15 Is a Predictor of Mortality in Critically Ill Patients with Sepsis

1Department of Medicine III, RWTH-University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany
2Medical Care Center, Dr. Stein and Colleagues, 41061 Mönchengladbach, Germany

Correspondence should be addressed to Lukas Buendgens; moc.liamg@snegdneubl

Received 8 May 2017; Accepted 31 July 2017; Published 18 October 2017

Academic Editor: Silvia Angeletti

Copyright © 2017 Lukas Buendgens et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Singer, C. S. Deutschman, C. W. Seymour et al., “The third international consensus definitions for sepsis and septic shock (sepsis-3),” The Journal of the American Medical Association, vol. 315, no. 8, pp. 801–810, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky, “Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care,” Critical Care Medicine, vol. 29, no. 7, pp. 1303–1310, 2001. View at Publisher · View at Google Scholar
  3. A. Lever and I. Mackenzie, “Sepsis: definition, epidemiology, and diagnosis,” British Medical Journal, vol. 335, no. 7625, pp. 879–883, 2007. View at Publisher · View at Google Scholar
  4. A. Kumar, D. Roberts, K. E. Wood et al., “Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock,” Critical Care Medicine, vol. 34, no. 6, pp. 1589–1596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Zambon, M. Ceola, R. Almeida-de-Castro, A. Gullo, and J.-L. Vincent, “Implementation of the surviving sepsis campaign guidelines for severe sepsis and septic shock: we could go faster,” Journal of Critical Care, vol. 23, no. 4, pp. 455–460, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Pierrakos and J.-L. Vincent, “Sepsis biomarkers: a review,” Critical Care, vol. 14, no. 1, article R15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Kempf, M. Eden, J. Strelau et al., “The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury,” Circulation Research, vol. 98, no. 3, pp. 351–360, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Böttner, C. Suter-Crazzolara, A. Schober, and K. Unsicker, “Expression of a novel member of the TGF-β superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues,” Cell and Tissue Research, vol. 297, no. 1, pp. 103–110, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. M. R. Bootcov, A. R. Bauskin, S. M. Valenzuela et al., “MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 21, pp. 11514–11519, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Kempf, R. Horn-Wichmann, G. Brabant et al., “Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay,” Clinical Chemistry, vol. 53, no. 2, pp. 284–291, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Q. Khan, K. Ng, O. Dhillon et al., “Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction,” European Heart Journal, vol. 30, no. 9, pp. 1057–1065, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Kempf, E. Björklund, S. Olofsson et al., “Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction,” European Heart Journal, vol. 28, no. 23, pp. 2858–2865, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. K. C. Wollert, T. Kempf, T. Peter et al., “Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome,” Circulation, vol. 115, no. 8, pp. 962–971, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Lankeit, T. Kempf, C. Dellas et al., “Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 9, pp. 1018–1025, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. N. Breit, J. J. Carrero, V. W. Tsai et al., “Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease,” Nephrology, Dialysis, Transplantation, vol. 27, no. 1, pp. 70–75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. J. E. Ho, S. J. Hwang, K. C. Wollert et al., “Biomarkers of cardiovascular stress and incident chronic kidney disease,” Clinical Chemistry, vol. 59, no. 11, pp. 1613–1620, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. B. J. Clark, T. M. Bull, A. B. Benson et al., “Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study,” Critical Care, vol. 17, no. 3, article R92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. E. C. Hsiao, L. G. Koniaris, T. Zimmers-Koniaris, S. M. Sebald, T. V. Huynh, and S. J. Lee, “Characterization of growth-differentiation factor 15, a transforming growth factor β superfamily member induced following liver injury,” Molecular and Cellular Biology, vol. 20, no. 10, pp. 3742–3751, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. T. A. Zimmers, X. Jin, E. C. Hsiao et al., “Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms,” The Journal of Surgical Research, vol. 130, no. 1, pp. 45–51, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. D. A. Brown, J. Moore, H. Johnen et al., “Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction,” Arthritis & Rheumatology, vol. 56, no. 3, pp. 753–764, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Corre, B. Hébraud, and P. Bourin, “Concise review: growth differentiation factor 15 in pathology: a clinical role?” Stem Cells Translational Medicine, vol. 2, no. 12, pp. 946–952, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Mueller, I. Leitner, M. Egger, M. Haltmayer, and B. Dieplinger, “Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases,” Clinica Chimica Acta, vol. 445, pp. 155–160, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Dieplinger, M. Egger, I. Leitner et al., “Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients,” Journal of Critical Care, vol. 34, pp. 38–45, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Koch, O. A. Gressner, E. Sanson, F. Tacke, and C. Trautwein, “Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients,” Critical Care, vol. 13, no. 3, article R95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Koch, E. Sanson, S. Voigt, A. Helm, C. Trautwein, and F. Tacke, “Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients,” Journal of Critical Care, vol. 26, no. 2, pp. 166–174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Koch, S. Voigt, E. Sanson et al., “Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients,” Critical Care, vol. 15, no. 1, article R45, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Koch, E. Sanson, A. Helm, S. Voigt, C. Trautwein, and F. Tacke, “Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis,” Critical Care, vol. 14, no. 3, article R94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Koch, S. Voigt, C. Kruschinski et al., “Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients,” Critical Care, vol. 15, no. 1, article R63, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Ray, Y. Le Manach, B. Riou, and T. T. Houle, “Statistical evaluation of a biomarker,” Anesthesiology, vol. 112, no. 4, pp. 1023–1040, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Kempf and K. C. Wollert, “Growth-differentiation factor-15 in heart failure,” Heart Failure Clinics, vol. 5, no. 4, pp. 537–547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. F. E. Wiklund, A. M. Bennet, P. K. Magnusson et al., “Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality,” Aging Cell, vol. 9, no. 6, pp. 1057–1064, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. George, A. Jena, V. Srivatsan, R. Muthukumar, and V. E. Dhandapani, “GDF 15-a novel biomarker in the offing for heart failure,” Current Cardiology Reviews, vol. 12, no. 1, pp. 37–46, 2016. View at Publisher · View at Google Scholar
  33. A. Nichol, M. Bailey, M. Egi et al., “Dynamic lactate indices as predictors of outcome in critically ill patients,” Critical Care, vol. 15, no. 5, article R242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. P. X. Li, J. Wong, A. Ayed et al., “Placental transforming growth factor-β is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression,” The Journal of Biological Chemistry, vol. 275, no. 26, pp. 20127–20135, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Roth, M. Junker, I. Tritschler et al., “GDF-15 contributes to proliferation and immune escape of malignant gliomas,” Clinical Cancer Research, vol. 16, no. 15, pp. 3851–3859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. G. A. Bonaterra, S. Zügel, J. Thogersen et al., “Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent inflammatory response to vascular injury,” Journal of the American Heart Association, vol. 1, no. 6, article e002550, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Xu, Z. Li, and W. Gao, “Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside,” Biomarkers, vol. 16, no. 6, pp. 466–475, 2011. View at Publisher · View at Google Scholar · View at Scopus